These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8039724)

  • 1. ApoE: new risk factor for Alzheimer's.
    Butler RN
    Geriatrics; 1994 Aug; 49(8):10-1. PubMed ID: 8039724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular genetics of apolipoprotein E and its receptors, implications for genetic risk factors of Alzheimer's disease].
    Okuizumi K; Tsuji S
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1460-4. PubMed ID: 8741397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apolipoprotein E genotypes in patients investigated for dementia].
    Johannsen P; Jakobsen JK; Jørgensen AL
    Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE-epsilon 4 and early-onset Alzheimer's.
    Okuizumi K; Onodera O; Tanaka H; Kobayashi H; Tsuji S; Takahashi H; Oyanagi K; Seki K; Tanaka M; Naruse S
    Nat Genet; 1994 May; 7(1):10-1. PubMed ID: 8075630
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.
    Bullido MJ; Artiga MJ; Recuero M; Sastre I; García MA; Aldudo J; Lendon C; Han SW; Morris JC; Frank A; Vázquez J; Goate A; Valdivieso F
    Nat Genet; 1998 Jan; 18(1):69-71. PubMed ID: 9425904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
    Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease.
    Bullido MJ; Valdivieso F
    Microsc Res Tech; 2000 Aug; 50(4):261-7. PubMed ID: 10936877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
    van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
    Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
    Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
    Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
    Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
    Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
    Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Alzheimer-apoE4 connection].
    Jørgensen AL
    Ugeskr Laeger; 1993 Nov; 155(48):3936-7. PubMed ID: 8273205
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme that detoxifies cancer drug linked to risk of Alzheimer's disease.
    Oncology (Williston Park); 1998 May; 12(5):777. PubMed ID: 9597686
    [No Abstract]   [Full Text] [Related]  

  • 16. APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.
    Nicoll JA; McCarron MO
    Amyloid; 2001 Jul; 8 Suppl 1():51-5. PubMed ID: 11676291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
    Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
    Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and the apolipoprotein E epsilon 4 allele.
    Friedman G; Ben Yehuda A
    Isr J Med Sci; 1994 Jul; 30(7):545-7. PubMed ID: 8050887
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E4: phenotype in patients with Alzheimer's disease.
    Mahieux F; Couderc R; Moulignier A; Bailleul S; Podrabinek N; Laudet J
    Ann Neurol; 1994 Apr; 35(4):506-7. PubMed ID: 8154882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.